Modulation of the tumor suppressor protein α-catenin by ischemic microenvironment

American Journal of Pathology

Volumn 175, Issue 4, 2009, Pages 1662-1674

  Plumb, Claire L ^a   Adamcic, Una ^a   Shahrzad, Siranoush ^a   Minhas, Kanwal ^a   Adham, Sirin A I ^a   Coomber, Brenda L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENIC ACTIVITY; CARCINOMA CELL; COLORECTAL CARCINOMA; CONTROLLED STUDY; GROWTH RATE; HUMAN; HUMAN CELL; ISCHEMIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 73549115416     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090007     Document Type: Article

References (63)

1. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
2. Nicolson GL: Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metastasis Rev 1984, 3:25-42
3. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G: A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998, 392:190-193
4. Wijnhoven BP, Dinjens WN, Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000, 87:992-1005
5. Zavadil J, Bottinger EP: TGF-β and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774
6. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7:131-142
7. Furukawa Y, Nakatsuru S, Nagafuchi A, Tsukita S, Muto T, Nakamura Y, Horii A: Structure, expression and chromosome assignment of the human catenin (cadherin-associated protein) α 1 gene (CTNNA1). Cytogenet Cell Genet 1994, 65:74-78
8. McPherson JD, Morton RA, Ewing CM, Wasmuth JJ, Overhauser J, Nagafuchi A, Tsukita S, Isaacs WB: Assignment of the human α-catenin gene (CTNNA1) to chromosome 5q21-q22. Genomics 1994, 19:188-190
9. Nollet F, van Hengel J, Berx G, Molemans F, van Roy F: Isolation and characterization of a human pseudogene (CTNNAP1) for αE-catenin (CTNNA1): assignment of the pseudogene to 5q22 and the αE-catenin gene to 5q31. Genomics 1995, 26:410-413
10. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI: α-Catenin is a molecular switch that binds E-cadherin-β-catenin and regulates actin-filament assembly. Cell 2005, 123:903-915
11. Pokutta S, Drees F, Yamada S, Nelson WJ, Weis WI: Biochemical and structural analysis of α-catenin in cell-cell contacts. Biochem Soc Trans 2008, 36:141-147
12. Kobielak A, Pasolli HA, Fuchs E: Mammalian formin-1 participates in adherens junctions and polymerization of linear actin cables. Nat Cell Biol 2004, 6:21-30
13. Pappas DJ, Rimm DL: Direct interaction of the C-terminal domain of α-catenin and F-actin is necessary for stabilized cell-cell adhesion. Cell Commun Adhes 2006, 13:151-170
14. Scholten AN, Aliredjo R, Creutzberg CL, Smit VT: Combined E-cadherin, α-catenin, and β-catenin expression is a favorable prognostic factor in endometrial carcinoma. Int J Gynecol Cancer 2006, 16:1379-1385
15. Nelson WJ, Nusse R: Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004, 303:1483-1487
16. Reya T, Clevers H: Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850
17. Yan HX, Yang W, Zhang R, Chen L, Tang L, Zhai B, Liu SQ, Cao HF, Man XB, Wu HP, Wu MC, Wang HY: Protein-tyrosine phosphatase PCP-2 inhibits β-catenin signaling and increases E-cadherin-dependent cell adhesion. J Biol Chem 2006, 281:15423-15433
18. Gottardi CJ, Gumbiner BM: Distinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 2004, 167:339-349
19. Kang Y, Massague J: Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279
20. Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E: Hyperproliferation and defects in epithelial polarity upon conditional ablation of α-catenin in skin. Cell 2001, 104:605-617
21. Chan EF, Gat U, McNiff JM, Fuchs E: A common human skin tumour is caused by activating mutations in β-catenin. Nat Genet 1999, 21:410-413
22. Gat U, DasGupta R, Degenstein L, Fuchs E: De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 1998, 95:605-614
23. Bullions LC, Notterman DA, Chung LS, Levine AJ: Expression of wild-type α-catenin protein in cells with a mutant α-catenin gene restores both growth regulation and tumor suppressor activities. Mol Cell Biol 1997, 17:4501-4508
24. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, Takeichi M: Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization. Cell 1992, 70:293-301
25. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S, Hirohashi S: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992, 52:5770-5774
26. Watabe M, Nagafuchi A, Tsukita S, Takeichi M: Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 1994, 127:247-256
27. Van Hoorde L, Pocard M, Maryns I, Poupon MF, Mareel M: Induction of invasion in vivo of α-catenin-positive HCT-8 human colon-cancer cells. Int J Cancer 2000, 88:751-758
28. Matsubara S, Ozawa M: Expression of α-catenin in α-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures. Oncogene 2004, 23:2694-2702
29. Burks J, Agazie YM: Modulation of α-catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3. Oncogene 2006, 25:7166-7179
30. Dexter DL, Spremulli EN, Fligiel Z, Barbosa JA, Vogel R, VanVoorhees A, Calabresi P: Heterogeneity of cancer cells from a single human colon carcinoma. Am J Med 1981, 71:949-956
31. Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM: Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells. Cancer Res 1995, 55:4722-4728
32. Calabresi P, Dexter DL, Heppner GH: Clinical and pharmacological implications of cancer cell differentiation and heterogeneity. Biochem Pharmacol 1979, 28:1933-1941
33. Vermeulen SJ, Chen TR, Speleman F, Nollet F, Van Roy FM, Mareel MM: Did the four human cancer cell lines DLD-1. HCT-15, HCT-8, and HRT-18 originate from one and the same patient? Cancer Genet Cytogenet 1998, 107:76-79
34. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP: p53 mutations in colorectal cancer, Proc Natl Acad Sci USA 1990, 87:7555-7559
35. Vermeulen SJ, Debruyne PR, Marra G, Speleman FP, Boukamp P, Jiricny J, Cuthbert AP, Newbold RF, Nollet FH, van Roy FM, Mareel MM: hMSH6 deficiency and inactivation of the αE-catenin invasion-suppressor gene in HCT-8 colon cancer cells. Clin Exp Metastasis 1999, 17:663-668
36. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790
37. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T: Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 1993, 260:85-88
38. Shahrzad S, Quayle L, Stone C, Plumb C, Shirasawa S, Rak JW, Coomber BL: Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression. Cancer Res 2005, 65:8134-8141
39. Shahrzad S, Shirasawa S, Sasazuki T, Rak JW, Coomber BL: Lowdose metronomic cyclophosphamide treatment mediates ischemia-dependent K-ras mutation in colorectal carcinoma xenografts. Oncogene 2008, 27:3729-3738
40. Roe S, Koslov ER, Rimm DL: A mutation in α-catenin disrupts adhesion in clone A cells without perturbing its actin and β-catenin binding activity. Cell Adhes Commun 1998, 5:283-296
41. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB: Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 2004, 18:754-756
42. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P: Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 2004, 18:703-10
43. Nakayama GR, Caton MC, Nova MP, Parandoosh Z: Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol 1997, 204:205-8
44. Papaioannou VE, Fox JG: Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci 1993, 43:189-192
45. Fathers KE, Stone CM, Minhas K, Marriott JJ, Greenwood JD, Dumont DJ, Coomber BL: Heterogeneity of Tie2 expression in tumor microcirculation: influence of cancer type, implantation site, and response to therapy. Am J Pathol 2005, 167:1753-1762
46. Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS, Coomber BL: Heterogeneous vascular dependence of tumor cell populations. Am J Pathol 2001, 158:1325-1334
47. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N, Rak JW: Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005, 105:1734-1741
48. Tucker RW, Sanford KK, Handleman SL, Jones GM: Colony morphology and growth in agarose as tests for spontaneous neoplastic transformation in vitro. Cancer Res 1977, 37:1571-1579
49. Chaplin DJ, Durand RE, Olive PL: Cell selection from a murine tumour using the fluorescent probe Hoechst 33342. Br J Cancer 1985, 51:569-572
50. Rosenthal KL, Tompkins WA, Frank GL, McCulloch P, Rawls WE: Variants of a human colon adenocarcinoma cell line which differ in morphology and carcinoembryonic antigen production. Cancer Res 1977, 37:4024-4030
51. Tompkins WA, Watrach AM, Schmale JD, Schultz RM, Harris JA: Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst 1974, 52:1101-1110
52. Agazie YM, Hayman MJ: Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol Cell Biol 2003, 23:7875-7886
53. Vécsey-Semjén B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA: Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Oncogene 2002, 21:4646-4662
54. Debruyne PR, Vermeulen SJ, Berx G, Pocard M, Correia da Rocha AS, Li X, Cirnes L, Poupon MF, van Roy FM, Mareel MM: Functional and molecular characterization of the epithelioid to round transition in human colorectal cancer LoVo cells. Oncogene 2003, 22:7199-7208
55. Woerner SM, Kloor M, von Knebel Doeberitz M, Gebert JF: Microsatellite instability in the development of DNA mismatch repair deficient tumors. Cancer Biomark 2006, 2:69-86
56. Schwartz S Jr, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M: Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999, 59:2995-3002
57. da Costa LT, Liu B, el-Deiry W, Hamilton SR, Kinzler KW, Vogelstein B, Markowitz S, Willson JK, de la Chapelle A, Downey KM, So AC: Polymerase δ variants in RER colorectal tumours. Nat Genet 1995, 9:10-11
58. Li HR, Shagisultanova EI, Yamashita K, Piao Z, Perucho M, Malkhosyan SR: Hypersensitivity of tumor cell lines with microsatellite instability to DNA double strand break producing chemotherapeutic agent bleomycin. Cancer Res 2004, 64:4760-4767
59. Lamlum H, Papadopoulou A, Ilyas M, Rowan A, Gillet C, Hanby A, Talbot I, Bodmer W, Tomlinson I: APC mutations are sufficient for the growth of early colorectal adenomas, Proc Natl Acad Sci USA 2000, 97:2225-2228
60. Vermeulen SJ, Nollet F, Teugels E, Vennekens KM, Malfait F, Philippe J, Speleman F, Bracke ME, van Roy FM, Mareel MM: The αE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene 1999, 18:905-915
61. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB: Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res 1993, 53:3585-3590
62. Oda T, Kanai Y, Shimoyama Y, Nagafuchi A, Tsukita S, Hirohashi S: Cloning of the human α-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem Biophys Res Commun 1993, 193:897-904
63. Vanpoucke G, Nollet F, Tejpar S, Cassiman JJ, van Roy F: The human αE-catenin gene CTNNA1: mutational analysis and rare occurrence of a truncated splice variant. Biochim Biophys Acta 2002, 1574:262-268